The Peter Attia Drive cover art

The Peter Attia Drive

The Peter Attia Drive

By: Peter Attia MD
Listen for free

This Season's Biggest Deal | $0.99/mo for 3 months + $20 Audible bonus

Auto-renews at $8.99/mo. after 3 months - terms apply.
Summary
The Peter Attia Drive will feature guests and experts that will offer advice and insight to help you optimize performance, health, longevity, critical thinking, and life. It's hosted by Stanford M.D., TED speaker, and longevity expert Dr. Peter Attia, founder of Attia Medical, PC, a medical practice with offices in San Diego and New York City.Copyright © Peter Attia, MD Exercise & Fitness Fitness, Diet & Nutrition Hygiene & Healthy Living Physical Illness & Disease
Episodes
  • #416 ‒ The science of mitochondria: their role in health, aging, and disease, and what the evidence says about drugs and supplements aimed at improving their function | Navdeep Chandel, Ph.D.
    Nov 16 2026
    View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this episode, Peter welcomes back Nav Chandel, a distinguished professor and world-renowned expert in mitochondrial biology, for a conversation that challenges many conventional assumptions about mitochondria and their role in health and aging. Nav begins by explaining what mitochondria do beyond ATP production, emphasizing their critical role in cellular communication and signaling. He explores how mitochondria communicate through hydrogen peroxide, metabolites, and mitochondrial DNA and RNA, and how these signals influence inflammation, immune function, and epigenetic regulation. The conversation then turns to the relationship between mitochondrial dysfunction and aging, including what the term "mitochondrial dysfunction" actually means and why it is often misused. Drawing on his own research, Nav takes a deep dive into metformin, explaining its effects on mitochondrial function, metabolism, and inflammation. He examines the evidence for its potential benefits in preventing age-related diseases and why findings from cancer trials have been disappointing. Finally, Nav offers an evidence-based assessment of popular mitochondrial supplements and interventions, including urolithin A, alpha-ketoglutarate, methylene blue, and hyperbaric oxygen. Throughout the discussion, Peter and Nav separate established science from speculation, providing a clearer understanding of mitochondrial biology and its implications for health and longevity. We discuss: Mitochondrial function: energy production, cellular building blocks, and signaling beyond the powerhouse model [3:30];Electron transport and reactive oxygen species: how mitochondrial energy production creates cellular signaling byproducts [9:45];Oxidative stress and aging: defining antioxidants and antioxidant systems, and the limits of supplementation [12:30];Mitochondrial signaling: metabolites, epigenetic regulation, and immune activation beyond ATP [20:15];How mitochondrial DNA and RNA can activate immune pathways and whether chronic low-level leakage contributes to long-term inflammation and aging [24:30];How mitochondrial release of cytochrome c can trigger cell death or stress signaling [28:30];Mitochondrial dysfunction: survival without mitochondrial ATP production, glycolytic compensation, and the central role of cellular signaling [29:45];How to assess one's mitochondrial function [34:00];The role of VO2 max and mitochondrial efficiency in maximizing your marginal decade [41:00];Mitochondrial dysfunction and aging [46:30];Metformin mechanisms: gut accumulation, complex I inhibition, and indirect effects on metabolism and exercise [52:45];Metformin and aging: does metformin provide true geroprotective benefits beyond glucose control? [1:04:00];Metformin and cancer: why most cancer trials have failed, and how its efficacy depends on tumor-specific uptake [1:08:15];How pollution and viral infections trigger inflammation, and the potential role of metformin as therapy [1:19:15];Clonal hematopoiesis, inflammation, and mitochondrial metabolism: metformin's role in limiting age-related immune dysregulation [1:22:45];Takeaways on the benefits and risks of using metformin as a geroprotective drug [1:24:45];Views on tests that claim to measure mitochondrial function [1:30:15];The Warburg effect and cancer metabolism: why Nav doesn't think mitochondria in cancer cells are dysfunctional [1:32:45];Mitochondrial supplements: urolithin A and berberine [1:35:00];Mitochondrial supplements: α-ketoglutarate [1:42:45];Mitochondrial supplements: citrulline, carnitine, CoQ10, NR, and NMN [1:45:00];Interventions touted to boost mitochondrial health: SS-31 and methylene blue [1:47:30];Hyperbaric oxygen and low-oxygen therapy: any real benefits for health and longevity? [1:51:15];Red light therapy: exploring its effects on mitochondria via cytochrome c oxidase and whether purported benefits have a real basis [1:55:30];The case for funding basic research to understand metabolism [1:59:45]; andMore. Connect With Peter on Twitter, Instagram, Facebook and YouTube
    Show More Show Less
    2 hrs and 7 mins
  • #415 ‒ AMA #91: Understanding lab testing: what blood work can and cannot tell you about your health and disease risk
    Nov 9 2026

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter's Weekly Newsletter

    In this "Ask Me Anything" (AMA) episode, Peter explores what laboratory testing can—and cannot—tell us about our health. Blood tests provide objective numbers and reference ranges, making them an appealing way to assess overall health. But their usefulness is far more nuanced than it may appear. Peter begins by explaining how to interpret lab results in the context of both lifespan and healthspan, emphasizing the importance of tracking changes over time rather than relying on isolated measurements. He then examines the strengths and limitations of blood testing for assessing risk across the major chronic diseases, including cardiovascular disease, metabolic dysfunction, cancer, and neurodegenerative disease. He explains what labs can reveal about organ health and where additional information from imaging, body composition, and functional testing is needed. The conversation also explores why more testing does not necessarily lead to better clinical decisions. Peter discusses the limitations of large direct-to-consumer testing panels and sophisticated measures such as lipid subfractionation and biological-age scores, particularly when the results lack clear clinical actionability. He also highlights the importance of physical function, cognitive performance, and emotional health—critical components of healthspan that cannot be adequately captured through blood work alone. Finally, Peter provides a practical framework for evaluating any laboratory test, understanding its limitations, and determining whether the results offer meaningful information that can guide decisions about health and longevity.

    If you're not a subscriber and are listening on a podcast player, you'll only be able to hear a preview of the AMA. If you're a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #91 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here.

    We discuss:

    • Why lab testing is insufficient to answer the question "Am I healthy?" [2:15];
    • Defining health through the lenses of lifespan, health span, and fundamental organ systems, and how labs can come up short [5:45];
    • The importance of longitudinal data, and the strengths and blind spots of labs for assessing cardiovascular disease risk [10:00];
    • Using labs to assess metabolic health, and the additional insights from body composition, behavior, and functional testing [18:45];
    • What blood tests and genetic testing can reveal about cancer detection and future cancer risk [23:00];
    • Assessing neurodegenerative disease risk through genetics, cardiometabolic markers, and emerging blood-based biomarkers [28:00];
    • What routine labs reveal about organ systems, and how to evaluate large direct-to-consumer testing panels [35:00];
    • Sophisticated tests that lack clinical actionability: lipid subfractionation, biological-age scores, and sleep scores [41:30];
    • Why labs provide limited insight into physical function, cognitive function, and emotional health [47:30];
    • A practical framework for interpreting any lab test, understanding its blind spots, and placing results in context [53:30]; and
    • More.

    Connect With Peter on Twitter, Instagram, Facebook and YouTube

    Show More Show Less
    17 mins
  • #414 ‒ Resistance training as we age: optimizing exercise selection and training intensity for muscle growth, function, and injury risk management | Jeff Cavaliere, M.S.P.T., C.S.C.S.
    Nov 2 2026

    View the Show Notes Page for This Episode

    Become a Member to Receive Exclusive Content

    Sign Up to Receive Peter's Weekly Newsletter

    In this episode, Peter welcomes back Jeff Cavaliere, a physical therapist, strength coach, and founder of ATHLEAN-X who has spent decades bridging the gap between rehabilitation, athletic performance, and strength training. Jeff begins by sharing how his experience working with professional athletes and managing his own injuries has shaped his approach to building strength and muscle while minimizing injury risk. He discusses how training should evolve as we age, particularly for those in their 40s, 50s, and beyond who want to continue making progress without compromising long-term joint health. Jeff explains why excessive training volume can be counterproductive and how to balance reps in reserve with training to failure to maximize results while managing fatigue and injury risk. He also explores the differences between training for aesthetics and functional performance, explaining why these goals are not necessarily at odds. The conversation then shifts to a muscle-by-muscle breakdown of effective exercises for building strength and hypertrophy. Jeff highlights common training mistakes, offers modifications for those dealing with pain or injury, and explains why often-neglected muscles deserve more attention. Finally, he walks through his "exercise graveyard," identifying popular exercises that may carry unnecessary injury risk and offering alternatives that deliver similar benefits with less risk. Throughout the episode, Jeff provides actionable guidance for making training more effective, sustainable, and adaptable as we age.

    We discuss:

    • Jeff's passion as an educator and the path that led him to build his YouTube channel [2:30];
    • Jeff's injury history and how he overcomes injury in training [11:00];
    • Qualities of great athletes and the tragedy of injury [20:15];
    • Tom Brady—an example of the value of pliability and consistency [24:30];
    • The athlete's mindset, how training changes in midlife, and the importance of a warm-up [28:15];
    • Reducing risk of injury in middle age and beyond: reps in reserve, training to failure, and junk volume [35:15];
    • How training intensity changes in midlife [44:30];
    • Hypertrophy: misconceptions and common mistakes when training shoulders [48:15];
    • Deltoid muscles of the shoulder: exercises beyond the overhead press [59:45];
    • Triceps: compound movements and exercises that target the long head [1:11:15];
    • Upper arm: best approaches for building hypertrophy and strength [1:21:00];
    • Biceps: nuance around training [1:24:30];
    • Forearm exercises that target the flexors and brachioradialis [1:31:45];
    • Pecs and chest: pressing and crossover movements [1:34:15];
    • Great abs: nutrition, rotation exercises, interval training, and more [1:45:30];
    • Back: exercises to create that V-shape [1:52:30];
    • Legs: training the quads, glutes, and more [2:02:00];
    • Calves: training the gastrocnemius and soleus [2:13:00];
    • Jeff's "exercise graveyard" and recommendations for modifications that achieve results with less risk of injury [2:21:00]; and
    • More.

    Connect With Peter on Twitter, Instagram, Facebook and YouTube

    Show More Show Less
    2 hrs and 29 mins
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.